Skip to main content
2026 Top #36 Fertility Clinic in the US 🏆 TOP 50

Source: Newsweek 2026 America's Best Fertility Clinics

Penn Fertility Care

US United States
· Philadelphia
SART·Society for Assisted Reproductive Technology ↗
member
CAP·College of American Pathologists ↗
accredited
CLIA·Clinical Laboratory Improvement Amendments ↗
certified
Top
Rated
Trusted hospital backed by real patient reviews
2.8
44
reviews
113
appointments
Book Now
Penn Fertility Care
Penn Fertility Care 2
Penn Fertility Care 3

About

About Penn Fertility Care

Penn Fertility Care is the fertility practice of the Perelman School of Medicine at the University of Pennsylvania, part of Penn Medicine. The main center sits at 3701 Market Street in University City, with additional offices at Washington Square and in Radnor. SART registers the practice as University of Pennsylvania - Penn Fertility Care, clinic number 0094. Clarisa R. Gracia, MD, MSCE is listed as medical and practice director; Dara S. Berger, PhD, HCLD directs the laboratory. Eleven reproductive endocrinology and infertility physicians are recorded here, and the service list in the SART record covers donor eggs, donor embryos, gestational carriers, egg and embryo freezing, PGD/PGS, ovarian tissue freezing, mental health services, and treatment for HIV-positive patients.

Our sources do not establish how long ART has been practiced at Penn. The registration number in this page’s record carries 1988, and the founding year field carries 1981, and neither is backed by a dated document we could reach: the clinic’s website sits behind an automated-access block, so this page makes no claim about being an early US program. Treat the year as an open question and ask the practice for its own history.

On results: the center reported 2,061 ART cycles for 2023 (SART Final, registration 0094). Live birth per intended retrieval, counting all embryo transfers, ran 57.7% under age 35 (246 cycles in that band), 46.4% at 35-37 (166), 32.2% at 38-40 (174), 16.3% at 41-42 (86) and 4.9% at 43 and older (41); the two oldest bands combine to 12.6% over 40. Weighting those five bands by their own cycle counts gives about 40.8% across all ages — that is our arithmetic on the published bands, not a figure SART reports as a single line. All four reported bands sit above SART’s 2023 national summary for the same registry and year, 53.2%, 39.9%, 26.2% and 9.4%, and the older-band leads come from the smallest denominators. Our record also carries a national per-clinic average of about 932 cycles for 2023; we do not turn that into a multiple, because that average is not one consistent number across our US data. Look at the size of each age group before treating any of these as a personal forecast, and pull the clinic’s own SART page for the full table.

Accreditations & Awards

  • SART member clinic reporting cycles to SART and the CDC (clinic number 0094, 2023 Final report), so the outcomes above are independently checkable rather than self-published
  • Two named professorships are documented in the physicians’ own profile records: Clarisa R. Gracia holds the Nancy and Richard Wolfson Professorship in Obstetrics and Gynecology, and Kurt T. Barnhart is the William Shippen, Jr. Professor of Obstetrics and Gynecology. Barnhart is also recorded as director of his school’s center for research in reproduction and women’s health and deputy director for reproductive medicine research
  • Medical and practice director: Clarisa R. Gracia, MD, MSCE, the physician named on this clinic’s SART report, with Dara S. Berger, PhD, HCLD named as laboratory director
  • Laboratory accreditation: not verified. Our sources could not confirm CAP or CLIA standing — the clinic’s website blocked automated access during data collection and the SART capture left its accreditation field blank. The registry record establishes SART membership only, so confirm lab certification directly when you tour
  • Volume: 2,061 cycles reported for 2023 under this one registration. We do not express that as a multiple of a national per-clinic average; the average recorded across our US data is not one consistent figure
  • What our sources do not carry for this clinic: no accreditation certificate numbers, no magazine or directory award list for the practice as a whole, and no documented program history dates

Why Choose Penn Fertility Care

  • Above the national row in every reported age band, with the denominator shown: 246 cycles under 35 in 2023 at 57.7%, not a rounded marketing percentage
  • A reproductive surgery center and an embryology laboratory of its own, with a named laboratory director in the SART record, so retrieval, freezing and transfer happen in-house rather than through an outside facility
  • Preservation options on the registered service list: egg, embryo and ovarian tissue freezing, all three filed as services of this clinic
  • Third-party reproduction handled routinely: donor egg, donor embryo and gestational carrier programs are all on the clinic’s registered service list
  • A PCOS program inside the division, directed by one of the eleven physicians on the roster
  • Research administration in the same department: the physicians’ own records place one of them at the head of the school’s center for research in reproduction and women’s health and as deputy director for reproductive medicine research, which is where trial access comes from
  • Three Philadelphia-area locations, so monitoring scans do not always mean a trip to University City
  • Support services listed in the registry record, including mental health services and treatment for HIV-positive patients
  • Not documented in our sources: an accredited laboratory certificate, per-physician outcomes, published prices, a program founding date, and the existence of specific sub-programs other pages sometimes credit to this division

IVF & Fertility Services

What follows is limited to what the SART service list and this clinic’s own record document. The registry does not publish cycle-level detail for every line, so ask how each service is run before you plan around it.

  • In Vitro Fertilization (IVF): stimulation, monitoring, transvaginal retrieval, fertilization and embryo transfer, with the laboratory on site
  • ICSI: injected fertilization, filed with IVF among this clinic’s registered services
  • PGT: the registered service list carries PGD/PGS, i.e. genetic testing of embryos before transfer
  • Egg freezing: egg cryopreservation is on the registered service list, for preservation before treatment that risks fertility and for patients planning later
  • Embryo freezing and frozen embryo transfer: embryo cryopreservation is on the same list. In the 2023 report, transfers of previously frozen embryos filed as additional transfers produced a live birth rate of 45.6% under 35 (103 thawed transfers) and 48.9% at 35-37 (94)
  • Ovarian tissue cryopreservation: also on the registered service list — rarer than egg or embryo banking, and worth asking about directly, since our sources give no volume or indication detail for it
  • Donor eggs and donor embryos: 2023 volumes were small — six frozen donor-egg starts, 56 transfers of thawed donor embryos at a 50.0% live birth rate, and ten donated-embryo transfers. Ask how many donor cycles the program runs in a typical year before you plan around it
  • Gestational carrier programs: listed as a registered service; the legal work around a carrier is the patient’s own responsibility
  • Reproductive surgery: the practice record describes a reproductive surgery center of its own, alongside the embryology laboratory. Our sources name no specific procedures, so bring your diagnosis to the consultation and ask what is done here
  • PCOS care: a PCOS program is documented inside the division
  • Male infertility evaluation: listed among the services this clinic provides
  • Mental health services: listed on the registered service list

Fees & Packages

There is no published price list. Our sources for this clinic record the fee section as unpublished — no cycle price, no medication price, no package — so any figure you are given verbally should come back to you in writing.

  • Insurance: what an employer plan pays varies, and our sources document no Pennsylvania statute that mandates infertility coverage for most plans. Ask your carrier for a written benefits determination before medications start, and note the name of the person who confirms it.
  • What to ask, since it is not published here: what a cycle fee includes, which items bill separately (monitoring, anesthesia for retrieval, freezing and storage, biopsy and laboratory work are the usual candidates at any clinic), what medication costs run on the protocol proposed for you, and whether any discount or financing route applies.
  • Third-party programs: donor-egg, donor-embryo and gestational-carrier paths involve agencies and lawyers outside the clinic. Our sources do not say which of those fees sit inside or outside a cycle price here, so get the split in writing before a matching fee is paid.

Patient Journey

The registry and the service record document what this practice does, not how long each step takes. No stimulation length, retrieval timing or test interval is published in our sources, so the steps below carry no day counts on purpose.

  1. Start the file. Call or book online; a first consultation can be held by telemedicine, which is the practical route for out-of-state and international patients
  2. Baseline testing: hormone panels, ovarian reserve assessment including AMH and antral follicle count, semen analysis where a partner is involved, and imaging of the uterine cavity. Our sources do not state how long results take
  3. Plan review with a physician, using this clinic’s own reported outcomes for your age band rather than a network average
  4. Stimulation and monitoring by bloodwork and ultrasound, with a trigger date set from follicle growth and hormone levels
  5. Retrieval, transvaginal, followed by fertilization — conventional insemination or ICSI — in the on-site laboratory. Our sources do not state the anesthesia used or the culture length chosen
  6. Freezing and testing: embryo biopsy where PGT is elected, and cryopreservation of eggs, embryos or ovarian tissue, all listed services here. Ask when extra banking time is scheduled into the cycle
  7. Transfer and confirmation: a fresh or frozen transfer, then a blood pregnancy test. Ask for the interval in writing; our sources give none, and progesterone support length is likewise unpublished here

Pennsylvania’s rules for assisted reproduction are thin in what we could reach: the legal record on this page points to case law rather than a dedicated statute, and our sources name no Pennsylvania ART code section. Read the bullets below as a starting point for a conversation with a lawyer, not as a summary of the law.

  • No comprehensive state statute on ART is documented in our sources, which cuts both ways: no state restriction on IVF, embryo freezing or PGT is recorded, and no statutory parentage or contract framework either
  • Gestational carriers: this page’s legal record states that Pennsylvania permits good-faith gestational carrier agreements, enforced through case law rather than a dedicated statute, and that Penn Fertility Care provides carrier services while the legal arrangements remain the patient’s responsibility. Independent reproductive-law counsel, for each side, before a cycle
  • Donation: donor egg and donor embryo programs are on this clinic’s registered service list. Our sources name no Pennsylvania statute governing donor anonymity or parentage for donors, so put information rights in the agreement
  • Coverage: our sources document no Pennsylvania mandate that most health plans cover infertility treatment
  • Clinic policy fills the gap: age cutoffs, embryo disposition and storage rules are set by the clinic, not by state code in what we could reach. Confirm them in writing at consultation, and read the disposition consent before embryos are created

Location

  • Address: 3701 Market St, 8th Floor, Suite 800, Philadelphia, PA 19104
  • Phone: +1 800-789-7366

Key Advantages

In Vitro Fertilization (IVF)
PGT-A Genetic Screening
LGBTQ+ Friendly

Location

3701 Market St, 8th Floor, Suite 800, Philadelphia, PA 19104

Facilities

Wheelchair Accessible
Parking
Multilingual Services

Medical Team

Patient Reviews

2.8
44 reviews
5star
65%
4star
20%
3star
8%
2star
4%
1star
3%
O
Oleksandr Zaytsev
1 week ago

Our family has been patients with PennMed since 2020,& at other network locations,our experience has generally been positive.The review reflects our personal experience at Penn Fertility Care regarding family planning with a known genetic risk FMR1/Fragile X syndrome,IVF,PGT-M.Before starting treatment,we asked whether the clinic had practical experience managing Fragile X cases.We were told they did,& our case was handled by Dr. Anuja Dokras.All 5 consultations were virtual;there were occasional tech delays, one lasting ~40 mins.Between appts,1–3 mos would pass, leaving us feeling we had limited time to discuss complex genetic questions & fully understand next steps amid uncertainty.We twice asked to switch MDs (at intake & early on, requesting a specific doctor), but were declined (see att.).After genetic counseling & 2 stimul cycles,we had serious questions about realistic chances of obtaining a healthy,transferable embryo with our own eggs.Cycle1:16 eggs retrieved,2 embryos formed,neither passed PGT-A.Cycle 2:14 eggs retrieved,1 embryo formed with the full mutation.Only after repeated inquiries,when a 3 cycle was proposed,did we receive an individualized estimate~10% chance per cycle.Factoring in~50% embryo transfer success rates,lab freeze/thaw risks,and the 94%+ probability that a 133-repeat maternal premutation expands to a full mutation (which eliminated transferring a female carrier embryo—something not clarified upfront),the cumulative odds were critically low.Pursuing 1 healthy embryo at any financial cost over an open-ended timeline felt like an unviable strategy without full upfront counseling.We respect clinical judgment & know IVF guarantees no specific outcome.However,we lacked an early,clearly explained picture of how age,the FMR1 premutation,& PGT-A/PGT-M results collectively affected our prognosis.A timely, candid discussion of alternatives,including donor eggs,before undergoing 2 costly,demanding cycles,could have spared us a heavy financial & emotional toll.Meeting with clinic leadership, we raised questions regarding strategy & communication.We were shown general IVF stats from genetics;however,we felt these generic figures didn't reflect our complex case.We were offered a $2,500 partial reimbursement for admin issues.While grateful for the gesture,it did not address our core concern-communication gaps& personalized planning.This review is not a claim of formal medical error, but a candid account.Penn Fertility Care,Dr. Anuja Dokras,& the HUP Patient Experience dept have real potential to improve how individualized prognoses are explained, how options are discussed early,& the culture of empathetic communication in complex genetic cases.We remain open to dialogue & sent a letter with full documentation to Penn Med's CEO & VPs,requesting an independent grievance review & fair resolution regarding fair reimbursement for care based on incomplete informed consent.Additional issues:Embryo storage: materials kept in cryo by default even when unusable;we learned about active fees only after an invoice. In cycle 2, we had to proactively file paperwork to stop storage of the affected embryo (see att.)Procedure: during a follow‑up,a fellow attempted catheter insertion twice unsuccessfully,causing discomfort until an attending MD completed it.Documented + discussed with leadership.Finance dept: non‑routine requests took 2–4 wks + repeated follow‑ups.A basic itemized bill for an employer grant had major delays. We were referred to ARC Fertility (13–18% APR) despite much lower personal credit rates.Recurring billing errors required insurance audits.Before prepayment,we received the wrong contract pkg,raising coordination concerns (see att.)This damaged trust.We give 2 stars to recognize dedicated nurses,clinical staff,& individual physicians who showed outstanding empathy & care.Fresh perspectives & positive leadership can drive real clinic improvement.Sincere thanks to Dr. Kathleen O'Neill,Dr. Marissa Weiss,Dr. Alexandra Taylor,Laura Swartz,procedure room nurses,& the front desk team.

A
Ashley Fioravanti
1 month ago

No accessible exam table. Pure greed to not have an updated electric raising exam table. Felt very unsafe getting an exam and my husband had to lift me on the table because I have muscular dystrophy.

A
Amanda B
3 months ago

I've found this clinic to be very supportive and helpful throughout this difficult process. Prior to starting my fertility journey, my doctor found an ovarian cyst that had to be removed. Dr. O'Neil was kind and thoughtful throughout that process. I unfortunately had an infection after surgery, and Dr O'Neil was very helpful and attentive as well as the nurses on staff. They gave me a lot of supplies to help heal my infection. Throughout this process every provider I've worked with has been amazing! They all answered my questions, and have been just very warm and welcoming which I feel like is very important in this setting. I trust my providers wholeheartedly and feel like they want this to succeed as much as I do. The clinic has also been very responsive through the portal. Whenever I send a message, Devenne responds very quickly with a thorough and kind response. The front desk staff and other office staff have been great, too. One day, during an appointment, the clinic was understaffed and running behind, and they provided snacks and drinks while we waited. Personally, I would recommend this clinic. Especially if you have PCOS and want providers that are very informed on PCOS.

E
Enrique Vargas
4 months ago

My wife and I had a great experience. The nurses explained everything clearly and made us feel comfortable the whole time. The surgical team checked on us afterward and even joked around a bit, which really helped ease the nerves. Overall, we felt well taken care of.

A
Alexandra Wilkins
5 months ago

Dr. Caitlin Martin is one of the most transactional, cold, and lacking in every form of compassion "professionals" my husband and I have ever worked with. How she is employed by this facility and continues to take on new patients is beyond…...

E
Emily SchiffEm
Edited 6 months ago

UPDATE: The poor communication continues, the link in their reply below does not work. I'm not surprised unfortunately. My dr and the ultrasound techs were very kind. Unfortunately I ran into a lot of issues with being given inaccurate information and misinformation coming from finance, nurses and front desk staff. Ultimately if you live in NJ I'd highly recommend RMA over Penn. Penn fertility does not have any offices in New Jersey, nor are there any Penn pharmacies. I felt like a lot of my care was not personalized and getting accurate information the first time around was impossible. I also had a major complication after my egg retrieval and ended up in the hospital for days. While I understand that this is a known risk, the communication afterwards from Penn was nothing short of terrible. I was sent a certified letter that was very nondescript and confusing. I was provided with several names and phone numbers to follow up with, and in the end was not able to speak with any of them. I was essentially told by staff " The state just makes us send that letter. You don't need to take any action". Don't provide patients with a communication and phone numbers to follow up with if you don't intend to allow that patient to speak with them.

J
Janine Beckles
1 year ago

The worst experience of my life and they were not clear what was going on with my body or AMH levels.

A
Andrea Collins
10 months ago

My initial consultation was overly optimistic, downplaying the statistical reality for my diagnosis. The financial counselor wasn't clear about the high likelihood of needing multiple cycles. This false hope made the eventual negative result even more crushing.

P
Paula Whitaker
10 months ago

We felt like a number in a factory. After our second failed cycle, there was no change to our protocol or a thorough review. The doctor was rushed and didn't recall our specific case details, making an emotional process feel cold and transactional.

Y
Yang X
Edited 1 year ago

One would expect a place associated with the name Penn to uphold the highest standards—but unfortunately, that has not been my experience. I underwent egg retrieval procedures with them. The number of mature eggs fell significantly below the expected average for women of my age. Despite assurances of adjustments for the second attempt, the outcome remained unchanged. This lack of improvement has raised doubts regarding their level of expertise in performing this procedure, given my experience. I requested evidence in the form of images of the retrieved eggs and feedback from the IVF meeting in December, but I didn’t received response. In addition to the unsatisfactory results, there were instances of negligence from the providers. During the first attempt, the drug for the trigger shot was not initially prescribed. I found out on the day I was scheduled for the shot. This necessitated a frantic last-minute trip to the HUP pharmacy (8/21/2023), barely obtaining the medication before closing time of the HUP pharmacy. A similar frustration also happened during the second attempt, the instructions regarding the injection of Lupron was confusing. Not only was the unit measurement left unexplained, but clarity on whether the Lupron received from the pharmacy was ready for use or required dilution was also lacking. As the injection was time sensitive, this lack of clarity forced me to make an urgent call. I am a biomedical researcher, and I had to use my own professional knowledge to reason the usage on November 9, 2023 I also filed a complaint at Patient & Guest Relations representative about all of my unsatisfactory experience on Mar.18 2024. Although I received their confirmation of receiving my complaint, but I didn’t received any response!! It is concerning that the entire process appears to lack adequate oversight. Patients continue to be charged substantial amounts—such as the $7,000 fee for potential additional rounds, due to the unsatisfactory outcome in the previous round. Unless the patient is willing to pursue legal action, it seems there is little recourse to hold them accountable for their misconduct. I hope this comment can at least help you decided where to go for fertility care if you have other options. Below are my comments to the reply of Penn Fertility Care: ---------------------------------------------------------------- thank you for your response, but let me emphasize this again. I did write everything last year using the link you provided. Although I receive a confirmation email, but no one actually process the issue afterwards. So, I have to say this: this patients/guest-relations website is useless and no one will really take care of the actual issues. The only way to hold you accountable probably would be an legal action, which many people can't afford!

Showing latest 10 reviews out of 44 total

Related Articles

Ready to start your fertility journey?

Get a personalized plan from our medical advisors

Free Consultation